HN2006037713A - Compuestos utiles en terapia - Google Patents

Compuestos utiles en terapia

Info

Publication number
HN2006037713A
HN2006037713A HN2006037713A HN2006037713A HN2006037713A HN 2006037713 A HN2006037713 A HN 2006037713A HN 2006037713 A HN2006037713 A HN 2006037713A HN 2006037713 A HN2006037713 A HN 2006037713A HN 2006037713 A HN2006037713 A HN 2006037713A
Authority
HN
Honduras
Prior art keywords
therapy
useful compounds
useful
derivatives
processes
Prior art date
Application number
HN2006037713A
Other languages
English (en)
Inventor
Anthony Bradley Paul
Neil Dack Kevin
Stephen Johnson Patrick
Elizabeth Skerratt Sara
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of HN2006037713A publication Critical patent/HN2006037713A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS COMPUESTOS Y A SUS DERIVADOS, QUE SON DE UTILIDAD EN TERAPIA Y A PROCESOS PARA SU PREPARACION
HN2006037713A 2005-11-08 2006-11-07 Compuestos utiles en terapia HN2006037713A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73509105P 2005-11-08 2005-11-08

Publications (1)

Publication Number Publication Date
HN2006037713A true HN2006037713A (es) 2010-06-09

Family

ID=37909834

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2006037713A HN2006037713A (es) 2005-11-08 2006-11-07 Compuestos utiles en terapia

Country Status (35)

Country Link
US (2) US7309712B2 (es)
EP (1) EP1948615B1 (es)
JP (1) JP4234786B1 (es)
KR (1) KR100997595B1 (es)
CN (1) CN101304974A (es)
AP (1) AP2008004463A0 (es)
AR (1) AR056780A1 (es)
AT (1) ATE537150T1 (es)
AU (1) AU2006313478A1 (es)
BR (1) BRPI0618630A2 (es)
CA (1) CA2628844C (es)
CR (1) CR9959A (es)
CY (1) CY1112286T1 (es)
DK (1) DK1948615T3 (es)
DO (1) DOP2006000245A (es)
EA (1) EA014693B1 (es)
EC (1) ECSP088431A (es)
ES (1) ES2376252T3 (es)
GT (1) GT200600478A (es)
HN (1) HN2006037713A (es)
IL (1) IL190806A0 (es)
MA (1) MA29940B1 (es)
NL (1) NL2000299C2 (es)
NO (1) NO20082504L (es)
PE (1) PE20070642A1 (es)
PL (1) PL1948615T3 (es)
PT (1) PT1948615E (es)
RS (1) RS20080191A (es)
SI (1) SI1948615T1 (es)
TN (1) TNSN08202A1 (es)
TW (1) TWI321563B (es)
UA (1) UA90763C2 (es)
UY (1) UY29904A1 (es)
WO (1) WO2007054770A2 (es)
ZA (1) ZA200803670B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934061T6 (en) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
RS20080191A (en) * 2005-11-08 2009-07-15 Pfizer Limited, Pyrazole derivatives and their medical use
WO2008014199A2 (en) 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 receptor
AU2007300295A1 (en) 2006-09-25 2008-04-03 Boehringer Ingelheim International Gmbh Compounds which modulate the CB2 receptor
WO2008135824A1 (en) * 2007-05-02 2008-11-13 Pfizer Limited Oxyalkylpyrazole compounds useful in therapy
EP2217565B1 (en) 2007-11-07 2013-05-22 Boehringer Ingelheim International GmbH Compounds which modulate the cb2 receptor
SG176464A1 (en) * 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US20120015988A1 (en) * 2008-05-13 2012-01-19 Boehringer Ingelheim International Gmbh Sulfone Compounds Which Modulate The CB2 Receptor
WO2010005782A1 (en) 2008-07-10 2010-01-14 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the cb2 receptor
NZ591111A (en) 2008-09-25 2013-08-30 Boehringer Ingelheim Int Sulfonyl compounds which selectively modulate the cb2 receptor
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
EP2443107B1 (en) 2009-06-16 2018-08-08 Boehringer Ingelheim International GmbH Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
EP2480544A1 (en) 2009-09-22 2012-08-01 Boehringer Ingelheim International GmbH Compounds which selectively modulate the cb2 receptor
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
WO2011088015A1 (en) 2010-01-15 2011-07-21 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8329735B2 (en) 2010-03-05 2012-12-11 Boehringer Ingelheim International Gmbh Tetrazole compounds which selectively modulate the CB2 receptor
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
US8846936B2 (en) 2010-07-22 2014-09-30 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the CB2 receptor
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
WO2020078402A1 (zh) * 2018-10-18 2020-04-23 南京圣和药业股份有限公司 作为TGF-βR1抑制剂的化合物及其应用
RU2711615C1 (ru) * 2019-09-12 2020-01-17 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ лечения эндометриоза на основании экспериментальной модели у крыс
CN111269097B (zh) * 2020-04-02 2023-02-17 苏州爱玛特生物科技有限公司 一种多元环双取代的1,3-丙二酮类化合物的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6281638A (ja) * 1985-10-07 1987-04-15 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
JPS63313784A (ja) * 1987-03-12 1988-12-21 Zeria Shinyaku Kogyo Kk 新規ピラゾール誘導体およびその製造法ならびにこれを有効成分とする抗潰瘍剤
DE4414792A1 (de) * 1993-08-11 1995-02-16 Bayer Ag Arzneimittel enthaltend 1-Thiocarbamoyl-5-hydroxypyrazolen und deren Verwendung als Mittel zur Bekämpfung des septischen Schocks
ME00558A (en) * 2001-04-10 2011-12-20 Pyrazole derivatives for treating hiv
GB0229618D0 (en) * 2002-12-19 2003-01-22 Cancer Rec Tech Ltd Pyrazole compounds
RS20080191A (en) * 2005-11-08 2009-07-15 Pfizer Limited, Pyrazole derivatives and their medical use

Also Published As

Publication number Publication date
CA2628844C (en) 2011-12-06
CN101304974A (zh) 2008-11-12
AR056780A1 (es) 2007-10-24
TNSN08202A1 (fr) 2009-10-30
AP2008004463A0 (en) 2008-06-30
ZA200803670B (en) 2009-03-25
EP1948615B1 (en) 2011-12-14
ES2376252T3 (es) 2012-03-12
US7425569B2 (en) 2008-09-16
AU2006313478A1 (en) 2007-05-18
ATE537150T1 (de) 2011-12-15
KR100997595B1 (ko) 2010-11-30
NL2000299A1 (nl) 2007-05-09
SI1948615T1 (sl) 2012-02-29
JP4234786B1 (ja) 2009-03-04
PT1948615E (pt) 2012-02-03
EP1948615A2 (en) 2008-07-30
MA29940B1 (fr) 2008-11-03
UY29904A1 (es) 2007-06-29
RS20080191A (en) 2009-07-15
NO20082504L (no) 2008-06-05
BRPI0618630A2 (pt) 2011-09-06
EA200801053A1 (ru) 2008-10-30
US20070105909A1 (en) 2007-05-10
US20080085919A1 (en) 2008-04-10
CR9959A (es) 2008-08-01
GT200600478A (es) 2007-06-08
TW200804295A (en) 2008-01-16
US7309712B2 (en) 2007-12-18
ECSP088431A (es) 2008-06-30
EA014693B1 (ru) 2010-12-30
CA2628844A1 (en) 2007-05-18
IL190806A0 (en) 2008-11-03
KR20080056761A (ko) 2008-06-23
WO2007054770A2 (en) 2007-05-18
CY1112286T1 (el) 2015-12-09
DK1948615T3 (da) 2012-02-06
DOP2006000245A (es) 2007-06-30
PL1948615T3 (pl) 2012-04-30
PE20070642A1 (es) 2007-08-24
WO2007054770A3 (en) 2007-10-04
UA90763C2 (ru) 2010-05-25
TWI321563B (en) 2010-03-11
JP2009514938A (ja) 2009-04-09
NL2000299C2 (nl) 2007-11-20

Similar Documents

Publication Publication Date Title
HN2006037713A (es) Compuestos utiles en terapia
ECSP088632A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina
CR11523A (es) Agentes fijadores y epitopos wise
GT200500269A (es) Procedimiento
CR10157A (es) Compuestos químicos
CR11427A (es) 2-fluoro-2 - desoxitetrahidrouridinas como inhibidores de citidina desaminasa
BRPI0815138A2 (pt) Métodos e organismos para a produção acoplada a crescimento de 1,4-butanodiol
CR11548A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
DK1879623T3 (da) Genterapi til rygmarvssygdomme
PA8667201A1 (es) Nuevos compuestos farmaceuticos
UY33124A (es) Agentes y epítopos enlazados a wise
CR9786A (es) Compuestos de bencimidazol-tiofeno
DOS2006000037S (es) Masticador para animales
DOS2006000032S (es) Masticador para animales
UY31563A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY31562A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
ME01459B (me) Postupak za doziranje medikamenata
UY31560A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
DOS2005000166S (es) Masticador para animales
DOS2006000034S (es) Masticador para animales
UY31688A1 (es) Plaguicidas
HN2006029142A (es) Proceso
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
DOS2006000033S (es) Masticador para animales
PA8624401A1 (es) Procesos para la preparacion de haluros de aril- y heteroaril-alquilsulfonilo